Lu X - Search Results

1

Nanobody-based CAR T cells targeting intracellular tumor antigens.

Li H, Zhong D, Luo H, Shi W, Xie S, Qiang H, Zhu L, Gao L, Liu J, Sun S, Ding Z, Yang X, Lu X. Li H, et al. Among authors: lu x. Biomed Pharmacother. 2022 Dec;156:113919. doi: 10.1016/j.biopha.2022.113919. Epub 2022 Oct 27. Biomed Pharmacother. 2022. PMID: 36411612 Free article.

2

Opportunities and Challenges for Antibodies against Intracellular Antigens.

Yang X, Xie S, Yang X, Cueva JC, Hou X, Tang Z, Yao H, Mo F, Yin S, Liu A, Lu X. Yang X, et al. Among authors: lu x. Theranostics. 2019 Oct 15;9(25):7792-7806. doi: 10.7150/thno.35486. eCollection 2019. Theranostics. 2019. PMID: 31695801 Free PMC article. Review.

3

Screening and antitumor effect of an anti‑CTLA‑4 nanobody.

Wan R, Liu A, Hou X, Lai Z, Li J, Yang N, Tan J, Mo F, Hu Z, Yang X, Zhao Y, Lu X. Wan R, et al. Among authors: lu x. Oncol Rep. 2018 Feb;39(2):511-518. doi: 10.3892/or.2017.6131. Epub 2017 Dec 4. Oncol Rep. 2018. PMID: 29207143 Free PMC article.

4

Prognostic Factors of Combined Periodontal and Endodontic Lesions: A Retrospective Study.

Guo J, Li Y, Lin X, Yang X, Shi W, Lu X. Guo J, et al. Among authors: lu x. Contrast Media Mol Imaging. 2022 Aug 22;2022:5042097. doi: 10.1155/2022/5042097. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 36051933 Free PMC article.

5

Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancer.

Mo F, Xue D, Duan S, Liu A, Yang X, Hou X, Lu X. Mo F, et al. Among authors: lu x. Vaccine. 2019 Feb 8;37(7):926-936. doi: 10.1016/j.vaccine.2019.01.004. Epub 2019 Jan 17. Vaccine. 2019. PMID: 30661833

6

Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers.

Yang X, Zhao J, Duan S, Hou X, Li X, Hu Z, Tang Z, Mo F, Lu X. Yang X, et al. Among authors: lu x. Theranostics. 2019 May 31;9(14):4066-4083. doi: 10.7150/thno.33383. eCollection 2019. Theranostics. 2019. PMID: 31281532 Free PMC article.

7

Highly sensitive detection of CTLA-4-positive T-cell subgroups based on nanobody and fluorescent carbon quantum dots.

Wang W, Hou X, Yang X, Liu A, Tang Z, Mo F, Yin S, Lu X. Wang W, et al. Among authors: lu x. Oncol Lett. 2019 Jul;18(1):109-116. doi: 10.3892/ol.2019.10320. Epub 2019 May 6. Oncol Lett. 2019. PMID: 31289479 Free PMC article.

8

The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.

Lai C, Duan S, Ye F, Hou X, Li X, Zhao J, Yu X, Hu Z, Tang Z, Mo F, Yang X, Lu X. Lai C, et al. Among authors: lu x. Theranostics. 2018 Feb 12;8(6):1723-1739. doi: 10.7150/thno.22056. eCollection 2018. Theranostics. 2018. PMID: 29556352 Free PMC article.

9

Anti-Tumor Activity of Mannose-CpG-Oligodeoxynucleotides-Conjugated and Hepatoma Lysate-Loaded Nanoliposomes for Targeting Dendritic Cells In Vivo.

Yang X, Lai C, Liu A, Hou X, Tang Z, Mo F, Yin S, Lu X. Yang X, et al. Among authors: lu x. J Biomed Nanotechnol. 2019 May 1;15(5):1018-1032. doi: 10.1166/jbn.2019.2755. J Biomed Nanotechnol. 2019. PMID: 30890232

10

Natural Single-Domain Antibody-Nanobody: A Novel Concept in the Antibody Field.

Li C, Tang Z, Hu Z, Wang Y, Yang X, Mo F, Lu X. Li C, et al. Among authors: lu x. J Biomed Nanotechnol. 2018 Jan 1;14(1):1-19. doi: 10.1166/jbn.2018.2463. J Biomed Nanotechnol. 2018. PMID: 29463363 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,958 results

Search Page

Filters